CONCLUSION-HbA1c can play a diagnostic role in acute medicine as it
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INTRODUCTION
Diabetes mellitus is a serious disease causing premature illness and death [1] . It can be asymptomatic for many years allowing serious diabetes related complications to develop [2] . Hospitalised patients are up to three times more likely to have diabetes (diagnosed or undiagnosed) than those in the community [3, 4] with acute hospital admissions rising in affluent countries in line with the aging population [5] [6] [7] .
Hyperglycaemia can be related to the particular acute medical event for which the patient is hospitalised [8] . In evolutionary terms, it is protective improving survival by allowing increased entry of glucose into crucial cells [9] . During hospitalisation, it is still debatable as to whether tight blood sugar control improves patient outcomes and is financially beneficial [10] . As hypoglycaemic episodes may be more problematical [11, 12] , different plasma glucose targets are recommended for patients with diabetes in these circumstances [13] .
Glucose measurement is essential on admission to hospital as this high risk group may not have been screened systematically in the community. Hyperglycaemia, a common response to stress associated with acute illness [9] , leads to poorer outcomes for patients by increasing morbidity and mortality [14] [15] [16] and lengthening hospitalization. It has been recognised as a major independent predictor of both inhospital congestive heart failure and mortality [15, 17] .
Current hospital practice involves blood glucose measurement using near patient or laboratory testing on admission with follow-up for certain patients in hospital and further testing after discharge. The American Diabetes Association (ADA) Clinical
Practice Recommendations for 2015 suggest using HbA 1c to identify hospitalised patients with undiagnosed diabetes [10] . Other existing guidelines for acute coronary M a n u s c r i p t
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As the uptake of HbA 1c as a diagnostic test in asymptomatic patients in the community has been considerable in the UK, [19, 20] , it is now important to assess its usefulness in acute medical admissions. In this study, OGTT were performed in 390 unselected, acute medical admissions identified with symptoms or possible complications of diabetes but no prior diagnosis of glucose dysregulation. No patients refused blood sampling during the study with an OGTT performed by the inpatient phlebotomy service on the ward either immediately if fasting or after a 12
MATERIALS AND METHODS

Inpatients
hour, overnight fast supervised by ward nursing staff.
Laboratory measurements
Venous blood was collected for glucose determination into serum tubes (Greiner BioOne Vacuette 2.5ml K3EDTA) either on admission to hospital or during the OGTT.
Glucose was measured in a routine laboratory on a Beckman LX 20 chemistry M a n u s c r i p t M a n u s c r i p t
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For the combined group of acute medical admissions comprising those newly diagnosed with diabetes on admission and those with diabetic symptoms and complications, the sensitivity of HbA 1c was estimated by a weighted average of the sensitivities of the two component groups. The weights used were the numbers of diagnoses of diabetes that would be expected for each component group within the study group of 2061 admissions if the calculated sensitivities were representative.
Based on a similar assumption, the specificity of the group with diabetic symptoms and complications was used as an estimate of the specificity of the combined group.
Receiver operating characteristic (ROC) curves were produced for i) the combined group, ii) the subgroup of acute medical admissions with possible symptoms or complications of diabetes and iii) the primary care patients at high risk of diabetes.
Fisher's Exact test was applied for comparisons of sensitivity and specificity. (14) were diagnosed with diabetes, p<0.001.
RESULTS
Dysglycaemia in acute medical admissions
Distribution of HbA 1c and glucose
Probability density functions demonstrate clearly the differences in HbA 1c between those diagnosed with diabetes immediately on admission, and symptomatic inpatients or at risk patients in the community, 
Sensitivity and specificity of HbA 1c for diabetes
The ability of HbA 1c to diagnose diabetes in GP patients was comparable to OGTT with the sensitivity being 93% (13/14) and specificity 96% (90/94), Fig. 3 . In the acute medical admissions studied, the specificity of HbA1c for diagnosis in those diagnosed immediately and those with possible symptoms or complications of diabetes was 99%, p=0.20, but the sensitivity was significantly lower at 38%, p<0.001. In those with possible symptoms or complications only, the sensitivity was 29% and specificity 99%. The sensitivity was higher for those diagnosed on fasting plasma glucose than for those diagnosed on 2h plasma glucose only at 63% (5/8) versus 23% (9/40), p=0.037.
DISCUSSION
Hospitals face an ongoing challenge on how to differentiate hyperglycaemia in inpatients. The ADA has moved the focus of diagnostic HbA 1c testing from asymptomatic patients in the community, to the large number of patients who remain undiagnosed in settings such as emergency or other hospital wards [10] . In addition to previously diagnosed or undiagnosed diabetes, hyperglycaemia in acutely ill patients may be induced by insulin resistance resulting from the stress of an acute medical event, or result from diabetes induced by glucotoxic drugs such as corticosteroids or antipsychotics.
In the white Caucasian patients at high risk of diabetes studied, the distribution of fasting plasma glucose on OGTT and HbA 1c was similar in acute admissions and primary care patients, Fig 2. The specificity of HbA 1c for diabetes was high in both populations justifying its use for diagnostic testing in hospital admissions, Fig.3 . M a n u s c r i p t immediately on admission had values >120 mmol/mol considered to be the trigger for urgent referral in the UK [19] . Audit data from an ethnically diverse UK region demonstrated that one in 200 HbA 1c results was above 120 mmol/mol and one in five patients had undiagnosed diabetes [20] .
Use of HbA 1c in these circumstances should improve the outcome for individual hospital patients. Its introduction requires assessment of i) the economic and financial situation by country, ii) the practical implications for the laboratory and point of care service, iii) the relationship of glucose to HbA 1c for different ethnic groups, and iv) the effects of medical conditions or drugs on the accuracy of HbA 1c relative to glucose [24] [25] [26] . The use of HbA 1c for diagnostic purposes in the community has been well received in the UK because of its practicality with laboratory requests for HbA 1c more than doubling since its introduction, glucose decreasing accordingly and requests for M a n u s c r i p t
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OGTT rare [27] .
There is not a perfect correlation between glucose and HbA 1c around the diagnostic cut-off points. Previous studies have shown that HbA 1c <37 mmol/mol (or 5.5%) and >58 mmol/mol (or 7.5%) correlate with OGTT at a 95% level but not so highly between 5.5% and 7.5% [28] . However, this data was analysed before the recent recalibration downwards of Tosoh and Bio-Rad analysers [29] . The lack of correlation around the diagnostic threshold may be attributed to normal variation in red blood cell turnover [30, 31] . The specificity and sensitivity of HbA 1c reported in this paper for the white Caucasian patients in primary care may reflect the prevalence of undiagnosed diabetes within the Irish population at the time of the study i.e. 2007
to 2008.
Certain medical conditions/drugs in individual patients can also affect red blood cell turnover. HbA 1c has been reported to be depressed by 20 mmol/mol in liver patients being assessed for transplantation [27] and up to 40mmol/mol in a patient with polycythaemia rubra vera [32] . There is not much quantitative evidence on the conditions that may compromise the accuracy of HbA 1c relative to glucose outlined by WHO in 2011 when recommending HbA 1c for diagnosis [22] .
Only one HbA 1c result was available for this study but the American Diabetes
Association has now suggested a more measured approach to confirmation of diagnoses. They suggest repeats only when feasible or within 3 to 6 months if around the diagnostic threshold [10] rather than within two weeks. In patients with very high Being able to discern whether a patient has stress hyperglycaemia is important as it is associated with worse outcomes for patients [33] [34] [35] . 
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FIGURE LEGENDS
Figure 1a
Flowchart for acute medical admissions identifying patients diagnosed with diabetes immediately and patients undergoing OGTT because of symptoms or complications of diabetes.
Figure 1b
Flowchart outlining patients in the community at risk of diabetes undergoing OGTT at GP practice. 
